Overview
Organisation / Company Josep Carreras Leukaemia Research Institute (IJC) Research Field Medical sciences » Cancer research Researcher Profile Other Profession Positions Bachelor Positions Country Spain
Offer Description
The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC). Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
We are looking for a Senior Translational Platform Technician in the field of biomedicine to join the Core Facilities Area. This new platform will be created at IJC as soon as possible.
Responsibilities
Write animal protocols to be officially approved by the Institutional Animal Care and Use Committee. Design preclinical anti-tumor therapeutic efficacy studies / experiments in partnership with professionals from the different IJC laboratories.
* Basic cell culture and proliferation assays (new single agent or drug combination). In vitro organoid culture of primary tumors.
* Tumor implantation and transplantation (s.c., i.v., intrasplenic, retro-orbital, etc) Bone marrow transplantation
* Pharmacokinetics, pharmacodynamics and toxicity studies of new treatments (compounds, drugs, etc.).
* Single agent or drug combination treatment, immunotherapy (CAR-T, bispecific antibodies, etc), gene therapy, hormonal studies and supportive therapies such as nutrition and pain management, among others).
* Tumor monitoring / treatment follow-up (tumor quantification method) using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and bioluminescent optical imaging (IVIs) techniques.
* Surgical procedures.
* Generate PDX mouse models (patient-derived xenografts).
* Genetically engineered mouse model (GEMM) management (breeding, genotype analysis, etc.)
* Experience in-vivo in techniques, animal models, PDX samples / patients-derived xenografts, pharmacology, advanced imaging techniques and drug development protocols is strongly preferred.
* Experience in vitro in Flow Cytometry and organoid model development.
* Capacity for analysis and data interpretation.
* Interest in translational research and collaborative team science
* Excellent communication skills and motivation to contribute to high impact research
* Proficient in writing and speaking in English.
* Ability to work independently and efficiently.
* Organized, self-motivated, and enthusiastic.
Languages ENGLISH Level Excellent
Research Field Medical sciences » Cancer research Years of Research Experience 1 - 4
Internal Application form(s) needed
* Full time contract (1623 hours per year)
* 1-year contract, with possibility to be extended, (“Indefinido por actividades científico técnicas”)linked to the implementation of the strategic plan supported by the Severo Ochoa funds associated to the accreditation of excellence.
* Measures to reconcile work and family life (flexible work schedule, teleworking, 23 working days of vacation and 9 days for personal matters).
* Flexible remuneration program (kindergarten and other measures).
* Training and development opportunities.
* Incorporation in a multinational and highly collaborative team.
* To work in a new strategic platform in the institute
* Mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
* Competitive Salary to be further defined depending on candidate experience.
* The stimulating environment of the IJC and its scientific network.
Selection process
DEADLINE FOR APPLICATIONS
Please submit your application by 01st September 2025 .
J-18808-Ljbffr
#J-18808-Ljbffr